- Last edited on June 1, 2023
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
|
cl:paraneoplastic-disorders [on June 1, 2023] psychdb [Primer] |
cl:paraneoplastic-disorders [on June 1, 2023] psychdb [Autoantibodies] |
||
|---|---|---|---|
| Line 10: | Line 10: | ||
| * **[[cl:0-autoimmune-encephalitis:anti-nmda-receptor|NMDAR-antibody encephalitis]]**, associated with ovarian teratomas in younger women | * **[[cl:0-autoimmune-encephalitis:anti-nmda-receptor|NMDAR-antibody encephalitis]]**, associated with ovarian teratomas in younger women | ||
| * Ophelia syndrome, associated with surface-directed **mGluR5-antibodies**, seen in patients with Hodgkin’s lymphoma | * Ophelia syndrome, associated with surface-directed **mGluR5-antibodies**, seen in patients with Hodgkin’s lymphoma | ||
| - | * **Anti-neuronal nuclear antibody-1 (ANNA-1)**, also known as **Hu** paraneoplastic encephalomyelitis, associated with small cell lung cancer in 75% of cases (other tumours include lung, prostate, breast, bladder, GI tract, ovary, neuroendocrine, unknown origin), most commonly in men. | + | * **Anti-neuronal nuclear antibody-1 (ANNA-1)**, also known as **anti-Hu** paraneoplastic encephalomyelitis, associated with small cell lung cancer in 75% of cases (other tumours include lung, prostate, breast, bladder, GI tract, ovary, neuroendocrine, unknown origin), most commonly in men. |
| * **AMPA receptor antibodies**, associated with lung, breast, thymus, ovarian tumours. | * **AMPA receptor antibodies**, associated with lung, breast, thymus, ovarian tumours. | ||